Investors

Minimum 15 minutes delayed. Source: LSEG

June 1, 2026

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Click here to read more

May 27, 2026

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Click here to read more

May 26, 2026

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

Click here to read more

See all News

Contact Us
Privacy Notice
Terms of Use

AXSOME and its logos are trademarks or registered trademarks of Axsome Therapeutics,Inc. or its affiliates. Other trademarks are property of their respective owners.

Investor
Relations

Investors

Email Alerts

Click here to subscribe to Axsome Therapeutics email alerts.